ArticleJournal of ovarian research2025
Complete response to Mirvetuximab Soravtansine in platinum-resistant recurrent ovarian cancer: a case report.
Yong Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it